You are here

Emergence of Anaplasma marginale antigenic variants during persistent rickettsemia.

TitleEmergence of Anaplasma marginale antigenic variants during persistent rickettsemia.
Publication TypeJournal Article
Year of Publication1999
AuthorsFrench, DM, Brown, WC, Palmer, GH
JournalInfect Immun
Volume67
Issue11
Pagination5834-40
Date Published1999 Nov
ISSN0019-9567
KeywordsAmino Acid Sequence, Anaplasma, Anaplasmosis, Animals, Antigens, Bacterial, Bacteremia, Bacterial Outer Membrane Proteins, Bacterial Proteins, Cattle, Cloning, Molecular, Humans, Molecular Sequence Data
Abstract

Anaplasma marginale is an ehrlichial pathogen of cattle, in the order Rickettsiales, that establishes persistent cyclic rickettsemia in the infected host. Within each rickettsemic cycle, A. marginale expressing antigenically variant major surface protein 2 (MSP2) emerge. By cloning 17 full-length msp2 transcripts expressed during cyclic rickettsemia, we determined that emergent variants have a single, central hypervariable region encoding variant B-cell epitopes. The N- and C-terminal regions are highly conserved among the expressed A. marginale variants, and similar sequences define the MSP2 homologues in the agent of human granulocytic ehrlichiosis (HGE). This is in contrast to the MSP2 homologues in ehrlichial genogroup I pathogens, Ehrlichia chaffeensis, Ehrlichia canis, and Cowdria ruminantium, that have multiple hypervariable regions. By defining the variable and conserved regions, we were able to show that the single hypervariable region of A. marginale MSP2 encodes epitopes that are immunogenic and induce variant-specific antibody responses during persistent infection. These findings demonstrate that the MSP2 structural variants that emerge during each cycle of persistent rickettsemia are true antigenic variants, consistent with MSP2 antigenic variation as a mechanism of A. marginale persistence.

Alternate JournalInfect. Immun.
PubMed ID10531237
PubMed Central IDPMC96963
Grant ListK08 AI01371 / AI / NIAID NIH HHS / United States
R01 AI44005 / AI / NIAID NIH HHS / United States